Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.35 |
| ▸ | THPO | P40225 | 2/20 | 0.35 |
| ▸ | GMNN | O75496 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | STAT6 | P42226 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL175503 | 0.89 | MAPK1 (0.35) | MAPK1TP53NFKB1THPOGMNN | |
| SCHEMBL29784882 | 0.88 | MAPK1 (0.31) | MAPK1TP53NFKB1THPOGMNN | |
| SCHEMBL28167123 | 0.87 | MAPK1 (0.33) | MAPK1TP53NFKB1THPOGMNN | |
| SCHEMBL11870982 | 0.85 | MAPK1 (0.33) | MAPK1TP53NFKB1THPOGMNN | |
| SCHEMBL741407 | 0.85 | MAPK1 (0.37) | MAPK1TP53NFKB1THPOGMNN | |
| SCHEMBL1860545 | 0.85 | MAPK1 (0.37) | MAPK1TP53NFKB1THPOGMNN | |
| SCHEMBL741406 | 0.85 | MAPK1 (0.37) | MAPK1TP53NFKB1THPOGMNN | |
| SCHEMBL9657732 | 0.84 | CPT2 (0.33) | — | |
| SCHEMBL9079101 | 0.84 | — | — | |
| SCHEMBL4453917 | 0.84 | CPT2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1585 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282908-A1 | FLUX AGENT AND SEMICONDUCTOR PACKAGE INCLUDING CURED PRODUCT THEREOF | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) | 2025-09-11 | — | — | US | claimed |
| US-12071566-B2 | Antimony-free radiation curable compositions for additive fabrication, and applications thereof in investment casting processes | STRATASYS INC. (US) | 2024-08-27 | — | — | US | claimed |
| US-20240076471-A1 | STABILIZED MATRIX-FILLED LIQUID RADIATION CURABLE RESIN COMPOSITIONS FOR ADDITIVE FABRICATION | STRATASYS, INC. (US) | 2024-03-07 | — | — | US | claimed |
| US-20240018297-A1 | POLYMERIZING COMPOSITION, METHOD OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | BASF SE (DE) | 2024-01-18 | — | — | US | claimed |
| US-20230287194-A1 | POLYMERIZING COMPOSITION, METHOD OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | THE UNIVERSITY OF MASSACHUSETTS | 2023-09-14 | — | — | US | claimed |
| CN-111542530-B | Epoxy resin containing phosphoric anhydride | 蓝立方知识产权有限责任公司 | 2023-08-22 | — | — | CN | claimed |
| US-11479638-B2 | Phosphorated anhydride containing epoxy resin | BLUE CUBE IP LLC (US) | 2022-10-25 | — | — | US | claimed |
| US-20220228010-A1 | ANTIMONY-FREE RADIATION CURABLE COMPOSITIONS FOR ADDITIVE FABRICATION, AND APPLICATIONS THEREOF IN INVESTMENT CASTING PROCESSES | STRATASYS INC. | 2022-07-21 | — | — | US | claimed |
| US-20220185987-A1 | STABILIZED MATRIX-FILLED LIQUID RADIATION CURABLE RESIN COMPOSITIONS FOR ADDITIVE FABRICATION | STRATASYS INC. | 2022-06-16 | — | — | US | claimed |
| CN-109503761-B | Stable matrix-filled liquid radiation curable resin compositions for additive fabrication | 科思创(荷兰)有限公司 | 2022-02-01 | — | — | CN | claimed |
| EP-1099138-B1 | STEREOLITHOGRAPHIC COMPOSITIONS FOR PREPARING POLYETHYLENE-LIKE ARTICLES | DSM IP ASSETS BV (NL) | 2003-09-24 | — | — | EP | claimed |
| EP-1269261-A2 | SOLID IMAGING COMPOSITIONS FOR PREPARING POLYPROPYLENE-LIKE ARTICLES | DSM N.V. (NL) | 2003-01-02 | — | — | EP | claimed |
| US-20020106584-A1 | Solid imaging compositions for preparing polypropylene-like articles | DSM IP ASSETS B.V. (NL) | 2002-08-08 | — | — | US | claimed |
| US-20020081505-A1 | Solid imaging compositions for preparing polypropylene-like articles | DSM DESOTECH INC. | 2002-06-27 | — | — | US | claimed |
| US-20020018959-A1 | Solid imaging compositions for preparing polypropylene-like articles | DSM IP ASSETS B.V. (NL) | 2002-02-14 | — | — | US | claimed |
| WO-2001075524-A2 | SOLID IMAGING COMPOSITIONS FOR PREPARING POLYPROPYLENE-LIKE ARTICLES | DSM N.V. (NL) | 2001-10-11 | — | — | WO | claimed |
| US-6287748-B1 | MIXTURE OF EPOXIDE, ACRYLIC MATERIAL, PHOTOINITIATOR, FREE RADICAL CATALYST | DSM N.V. (NL) | 2001-09-11 | — | — | US | claimed |
| EP-0605361-B1 | Photosensitive compositions | CIBA GEIGY AG (CH) | 1997-04-02 | — | — | EP | claimed |
| US-5476748-A | Containing liquid epoxy resin, acrylated ester, photointiator and hydroxyl terminated polyethers, polyesters, or polyurethanes | CIBA-GEIGY CORPORATION (US) | 1995-12-19 | — | — | US | claimed |
| EP-0605361-A2 | Photosensitive compositions | CIBA-GEIGY AG (CH) | 1994-07-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11479638-B2 | Phosphorated anhydride containing epoxy resin | CA1, CA3, P4HA1 | MAPK1 2638/4885TP53 3493/4885NFKB1 1430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.